Showing results (301-310 of 686) with videos related to
Sort By:
Pageof 69
Transplantation|April 1, 1993
Hepatic lidocaine metabolism and complications of cirrhosis. Implications for assessing patient priority for hepatic transplantationM L Shiffman, R A Fisher, A J Sanyal, et al.Annals of Hepatology|June 14, 2014
Long term changes in liver histology following treatment of chronic hepatitis C virusMitchell L Shiffman, Richard K Sterling, Melissa Contos, et al.Journal of Hepatology|March 8, 2025
Hot and cold fibrosis: The role of serum biomarkers to assess immune mechanisms and ECM-cell interactions in human fibrosisA Zawadzki, D J Leeming, A J Sanyal, et al.Nature Communications|November 6, 2023
A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitisPhilip N Newsome, Arun J Sanyal, Guy Neff, et al.Hepatology (Baltimore, Md.)|September 29, 2011
Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver diseaseKris V Kowdley, Patricia Belt, Laura A Wilson, et al.Transplantation|October 9, 1999
Right lobe living donor liver transplantationA Marcos, R A Fisher, J M Ham, et al.Cell Metabolism|May 8, 2012
Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver diseaseHae-Ki Min, Ashwani Kapoor, Michael Fuchs, et al.Journal of Visualized Experiments : Jove|August 9, 2016
Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density LipoproteinMulugeta Seneshaw, Faridoddin Mirshahi, Hae-Ki Min, et al.Journal of Patient-Reported Outcomes|July 1, 2025
NASH-CHECK patient-reported outcome instrument: evaluation of content and face validity for patients with metabolic dysfunction-associated steatohepatitis and compensated cirrhosisLynda C Doward, Matthew Breckons, Maria-Magdalena Balp, et al.Gastroenterology|February 21, 2016
Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1Thomas D Boyer, Arun J Sanyal, Florence Wong, et al.Pageof 69